Peter Kolchinsky
InvestorManaging Partner at RA Capital
Boston, Massachusetts
Writes $100K – $5M checks · typically $1.5M
FoundedCalimmuneG1 TherapeuticsIcosavaxLantos TechnologiesNature's ToolboxSojournix
Experience
- RA Capital ManagementManaging Partnercurrent2001 — presentBoston, MA
- No Patient Left BehindSteering Committee Membercurrent2020 — present
- National Academy of SciencesBoard Member, Board on Global Science and Technology2009 — 2012
Education
- Harvard UniversityDoctor of Philosophy (Ph.D.), Virology
- Cornell UniversityBachelor of Arts (B.A.), Biological Sciences
Same school
Also attended Cornell University559
+ 553 more
Shared employers
Also worked at National Academy of Sciences6
Deals · 11
Nature's ToolboxBoard seat
via RA Capital · filed May 2025 · $15M raise
Vaxess Technologies, Inc.Board seat
via RA Capital · filed Feb 2025 · $10M raise
Freenome HoldingsBoard seat
via RA Capital · filed Dec 2021 · $300M raise
ARS PharmaceuticalsBoard seat
via RA Capital · filed Sep 2021 · $55M raise
IcosavaxBoard seat
via RA Capital · filed Apr 2021 · $99.7M raise
SojournixBoard seat
via RA Capital · filed Nov 2018 · $44M raise
Antera TherapeuticsBoard seat
via RA Capital · filed Sep 2017 · $3.1M raise
Lantos TechnologiesBoard seat
via RA Capital · filed Aug 2017 · $3M raise
G1 TherapeuticsBoard seat
via RA Capital · filed Jul 2016 · $50M raise
CalimmuneBoard seat
via RA Capital · filed May 2015 · $16M raise
Wave Life SciencesBoard seat
via RA Capital · filed Feb 2015 · $11.8M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at RA Capital
Network2
Investors connected to Peter in public investor directories — a warm-intro map.






.png)












